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This month, Europe remembers the end of the second world war and reflects on 75 years of peace, 
and also celebrates the bicentenary of Florence Nightingale’s birth on 12th May 1820. The World 
Health Organisation designated 2020 the International Year of the Nurse and Midwife to mark 
Florence Nightingale’s birth; Florence Nightingale’s legacy is extensive, but she is perhaps most often 
associated with improvements in sanitation and infection control during her work in the Crimean 
war, and in gathering and using evidence, and those insights remain with us as we work to provide 
safe, high quality maternity care in the era of COVID-19. 
Amist these anniversaries, 2020 has also seen the rapid and unpredictable spread of COVID-19 
across Europe.  Although the evidence to date would suggest that pregnancy does not increase the 
likelihood of developing COVID-19 complications compared to non-pregnant population (Docherty et 
al 2020), and that vertical transmission appears to be unusual (Knight et al 2020), the clinical picture 
remains uncertain, and much more evidence is needed before we can be confident about these early 
indications.  However, what is clear that the burden of morbidity and death does not fall equitably. 
There is mounting evidence that COVID-19 disproportionately affects those from Black, Asian and 
Minority Ethnic backgrounds; a recent UK Obstetric Surveillance System (UKOSS) study (Knight et al., 
2020) of pregnant women hospitalised with COVID-19 found a clear association between 
hospitalisation and black and other minority ethnicity (aOR 4.49, 95%CI 3.37-6.00), and also that 
older women or those with raised BMI or other comorbidities were more likely to be hospitalised 
and require critical care. This observation, also seen in other countries which gather and report case 
ethnicity (Khunti et al., 2020), has shocked many; the reasons are not fully understood, but it is clear 
that people with BAME ethnicity, whether they are pregnant women, members of the public, 
essential workers or health care providers, need to be pro-actively protected from contracting 
COVID-19.  
         
A recent UKOSS report (Knight et al 2020) also revealed that five pregnant women in UK have died 
with or from COVID-19, although it is not yet known whether COVID-19 was the direct cause of 
death in these cases, and that 4.9 women per 1000 maternities were admitted to hospital with 
COVID-19, of whom 9% required respiratory support. Italy has also reported a maternal death with 
COVID-19; to date, other EU countries have not, but as many women remain hospitalised, this 
situation may change. 
In this editorial, we consider the impact that COVID-19 has had on maternity care in Europe, and 
examine how those countries most affected have had similar or different responses. The purpose of 
this is to share these experiences, show commonalities and differences where these exist, and to 
reflect on the impact of COVID-19 on maternity care in Europe, now and in the coming months. We 
acknowledge of course that the greatest burden of COVID-19 care provision, morbidity and death 
has fallen on those working in medicine, social care and nursing, in community care provision, in 
care homes, in mental health settings and in prisons; by comparison, midwives often care for healthy 
women at home or in low-acuity settings, and most pregnant women who contract COVID-19 have 
only mild disease (Knight et al 2020).  Yet women and midwives remain very much affected; care 
during pregnancy, birth and the postnatal weeks has changed radically and fast, and basic elements 
of the midwife-woman relationship such as meeting in person and providing a comforting touch 
have been upended in an attempt to maintain distance and reduce cross-infection. Women who 
have complex medical and obstetric conditions have had access to ‘face to face’ care reduced, whilst 
being encouraged to keep attending hospitals even as these are being recognised coronavirus ‘hot 
spots’. At the moment, we have no idea of the impact these necessary adjustments will have on 
women and babies’ wellbeing, or on women’s experiences of birth. 
Outside USA, European countries have had the highest number of COVID-19 cases and deaths; UK, 
Italy, Spain, France, Belgium and Netherlands are all amongst the top ten affected countries in the 
world (John Hopkins University 2020). In this context, concern about what constitutes safe care of 
         
pregnant women and newborns has increased, and in many settings, risk averse decisions have been 
taken in maternity care provision which, it is argued, may increase unnecessary medical 
interventions, put women at risk of being infected with COVID-19 by reducing provision of 
community or home based care, and reduce or reverse progression towards high quality maternity 
care (Renfrew et al 2020, forthcoming).  
Whilst it is very difficult to make comparisons between countries at this early stage, information 
about maternity care, and about the way that the pandemic has progressed in different regions, 
seems to show some common themes. We discuss these below, drawing on first-hand accounts 
from colleagues and clinicians in some of the affected countries.  Commonalities include concerns 
around supply of PPE, high numbers of healthcare staff affected by the virus, and steps taken to 
reduce pregnant women’s exposure to health settings by switching to online and telephone 
consultations where possible. Differences emerge in how labour care and choice of place of birth has 
been planned, the reductions in antenatal and postnatal ‘face to face’ care provision and in 
promotion of skin to skin contact and breastfeeding for COVID-19 positive women following birth. 
Changes to working practices in maternity care. 
Most EU countries moved to expand their healthcare workforces as the COVID-19 pandemic 
developed. Common responses were to invite recently retired staff back into general medical 
practice (reported in UK, Italy Netherlands, France and Spain) or to arrange for near-qualified 
students to start working in the health service as has happened in UK. In Spain, recently qualified 
medics have been deployed early into public healthcare before specialising, but have mainly 
undertaken administrative and non-patient facing work to release the wider workforce. In Spanish 
hospitals with open maternity units, midwives have stayed in maternity care, but staff in smaller 
hospitals which may have discharged lots of patients were redeployed elsewhere. Concerns about 
midwives being moved to medical wards in UK were addressed by the Royal College of Midwives, 
which made a strong case for maintaining maternity services in a context of staff shortage where 
         
many staff were self-isolating, sick or could not access child care cover for shifts. In the Netherlands, 
midwives’ training does not equip them to work in general medicine, and although retired midwives 
have been invited to return to practice, they have not been required to do so to date. 
Antenatal care 
Affected EU countries report similar changes to the care provided to pregnant women and their 
families since the COVID pandemic. It is worth reflecting that these changes have often been 
wholesale and widespread, occurring very suddenly and impacting on women already pregnant who 
had no advance warning that the care would change almost overnight. In the Netherlands, an initial 
online or phone consultation was followed by an initial visit to the midwife at 10-12 weeks for blood 
tests and early ultrasound.  Subsequent appointments were by phone or online but with regular 
growth assessment and BP checks.  Partners are not allowed to attend these face to face meetings. 
France and UK have also stopped most face to face consultations and replaced these with online and 
telephone consultations. In some areas of the UK, women have been provided with blood pressure 
machines and urinalysis sticks to undertake their own antenatal checks, and those with known or 
pre-existing hypertension were often already self-monitoring and using online apps to inform 
healthcare providers of their readings. In Italy, the Ministry of Health produced guidance for 
pregnancy but care still varied; some hospitals reduced antenatal clinics and used phone 
consultations, whilst face to face clinic appointments and home visits continued in others. In Spain, 
this has again varied, with some clinics continuing, and other hospitals moving to phone 
consultations.  
The changes to care are all designed to reduce the COVID-19 infection risk for pregnant women and 
staff, and whilst phone and online consultations can be acceptable and valued by women as an 
interim measure, these may also reduce the sense of genuine communication between women and 
midwives. They may create problems with care access for women with language problems or who 
lack IT resources and skills and could provide fewer opportunities to identify issues such as domestic 
         
violence. There are fewer opportunities to hear the fetal heartbeat, which can increase anxiety for 
women, especially those with complex pregnancies; other women may be disproportionately 
affected by additional anxiety due to language issues, mental health problems or learning 
disabilities.  Whilst many women will be well throughout pregnancy, these changes are experimental 
and the effect on outcomes is unknown; cases of pre-eclampsia and other antenatal complications 
could be missed, and anxiety about entering acute hospital settings might deter women from 
seeking additional care during pregnancy.  
Choice of place of birth, home birth and Midwife-Led Units 
In UK, where women have choice of place of birth, difficult decisions have had to be made about 
support for home births in areas severely affected by COVID-19. These have included re-allocation of 
midwifery-led birth centres to triage centres for pregnant women who present with symptoms of 
COVID-19. Some areas initially reduced and restricted home birth services or midwife-led care in 
birth centres, due to reduced staffing, or limited access to ambulance transfer. Others sought to 
maintain these in an effort to reduce unnecessary hospitalisation, and developed new protocols for 
transfer using, for example, private cars where the transfer is not clinically urgent. In April, NHS 
England (2020) released guidance that supported continued choice of place of birth and reiterated 
that home birth or midwife-led settings are safest for women at low risk of complications, noting 
that more women were requesting home birth as an alternative to hospital admission. The UK’s 
move to providing continuity of midwifery care appears to have been affected by COVID-19 
however. The Dutch midwifery association (KNOV 2020) published guidance which continued to 
emphasise that home birth was safe and that birth in outpatient settings should be considered 
where feasible, to reduce infection risk, enhance continuity models of midwifery to reduce number 
of caregivers in contact with women and babies, and report that women were choosing home births. 
Unused hotels were identified as potential birth settings as midwives may not be able to access 
community outpatient settings, but these have not been needed yet. In Italy, France and Spain, 
         
home birth and midwife led units are less common, and often provided privately, so most women 
have continued to give birth in hospitals. 
Care during birth and postnatal care 
Maternity providers have often severely limited visiting, and as in other EU countries, some UK 
hospitals have stopped allowing birth partners to be present, except during ‘active’ labour, although 
others have continued to support partner presence during labour and on the postnatal wards. There 
are also reports of even more stringent restrictions (such as partner visits limited to the birth itself 
and an hour following birth).This has also affected bereavement care as women are sent home more 
quickly after a miscarriage or stillbirth, and accounts of bereavement rooms being re-allocated to 
the care of women who have COVID-19.  
These changes have led to concerns about women’s rights to partner support during labour and 
after birth, access to pain relief and access to water birth, and the UK Birthrights organisation 
responded with guidance for women in relation to their rights during coronavirus (Birthrights, 2020). 
In the Netherlands, only one person can be present during labour, and partners could attend even if 
they have symptoms of COVID-19, as long as PPE was available and symptomatic partners 
maintained their distance. In France, partners can be present but are asked to wear a face mask, and 
in Spain, government guidance supports one supporter being present with women during labour, 
but practice varies between hospitals. In Italy, epidural services were withdrawn at times in the most 
affected regions, as anaesthetists were redeployed to urgent care for coronavirus patients and other 
EU countries have certainly prepared guidance for this scenario. This is clearly something which 
would only occur in extremis, but the anxiety this may cause to women, partners and midwives 
caring for them is clear. 
Another area of variation is postnatal care. World Health Organisation (WHO, 2020) COVID-19 
guidance has consistently promoted continued skin to skin contact and breastfeeding, and most EU 
countries appear to have followed this approach, only separating women and babies if the baby 
         
requires NICU care. As the current evidence suggests that women who are hospitalised with COVID-
19 are more likely to have preterm births (Knight et al 2020), this will be a more common outcome 
that usual. Breastfeeding and skin to skin contact have continued in most EU countries but women 
are being advised to wear face masks and take hygiene precautions to reduce the risk of 
transmission to babies, which is consistent with current WHO guidance. In Spain, some hospitals 
have isolated COVID-19 positive women from their babies, with no skin to skin contact or 
breastfeeding until the mother tests negative, whilst others have kept COVID-19 positive and 
symptomatic women with their babies, encouraging usual skin to skin and breastfeeding care; in 
cases where symptomatic women have been separated because the woman’s condition requires it, 
they have been supported to express breast milk or to breastfeed. These measures are undertaken 
in the context of uncertainty about risks to the neonate, and it appears that separation occurred 
more often in the early days of the pandemic, but recent research is reassuring; it appears that few 
babies acquire COVID-19 either by vertical transmission or by infection following birth, and that 
those babies who have acquired COVID-19 are likely to have mild disease (Knight et al 2020). On the 
other hand, the observed higher proportion of preterm births amongst women hospitalised with 
COVID-19 suggests that these babies may be at risk from the many complications of prematurity and 
that skin to skin contact and promotion of breastfeeding remain essential elements of care, although 
it remains unclear whether COVID-19 itself or other conditions are leading to the observed increase 
in prematurity in these cohorts.  
The situation for staff providing care to pregnant women and their families  
The changes detailed above were instigated to reduce risk to pregnant women and to health care 
workers, by expanding online consultations and limiting face to face contact, and visits to health care 
settings, as far as possible.  In UK, Italy and Spain, health systems struggled to provide sufficient PPE 
to staff, especially in the earlier days of the COVID-19 pandemic. Some European countries, including 
France and Netherlands, seem to have had better supply of PPE in hospitals, but in France, UK, Italy 
         
and Spain there are reports of community staff being left unprotected for longer, leading to 
midwives and General Practitioners seeing pregnant women without PPE. The provision of PPE for 
community midwives in the Netherlands started slowly; midwives had to compile their own PPE 
packages and received supplies from the community, such as from nail salons and veterinarians. In 
severely affected countries, including UK, Spain and Italy, midwives and other health clinicians 
describe feeling pressured to continue caring for hospitalised COVID-19 patients without basic PPE. 
A common experience has been frequent, fast changes to guidance and rapid cultural shifts; in early 
April, midwives in different UK Trusts anecdotally reported being criticised for ‘scaremongering’ by 
electing to wear surgical masks, and yet were called ‘irresponsible’ a few days later if they were not 
wearing masks for all contacts.  
The evidence informing effective use of PPE and the capacity of PPE to prevent transmission of 
respiratory disease is acknowledged to be incomplete, and to contain uncertainties (Verbeek et al 
2020). There have been reports that health workers have been more likely to be infected than the 
general public, but it is not yet clear whether this is the case, or whether they are more likely to be 
tested. In Europe, testing of staff and public has been notoriously variable and slow in places. Where 
staff have been tested, results appear variable – in the Netherlands, Cable News Network (CNN) 
reported that 26% of reported COVID-19 cases were amongst healthcare staff, whilst a prevalence 
study conducted amongst staff based in a hospital in Barcelona, Spain found that around 11% of 
staff had been infected by COVID-19 (Garcia-Basteiro et al., 2020).  A similar UK study found 24.4% 
seroconversion amongst staff in a Birmingham hospital (Shields et al 2020), and both studies 
reported that some staff seroconverted without experiencing symptoms of COVID-19. Although 
these reported rates reflect that health workers have access to testing when the public does not, the 
situation remains uncertain and this picture is certainly complicated by the lack of PPE protection 
provided in the early weeks of the pandemic. It raises the question of whether PPE can effectively 
prevent transmission of COVID-19, given human factors, supply issues and problems maintaining 
protocols in emergencies.  Not surprisingly, some health care workers feel they may be unsafe even 
         
with PPE and infection control measures, and remain concerned that they may transmit the virus to 
women, and to their own families and colleagues. Elsewhere in the world, the apparent ability of 
South Korea, Japan and China to reduce spread and limit mortality has been attributed to both 
proactive testing and tracing, access to PPE and widespread use and acceptance of facemasks 
amongst the public, although it is difficult to draw conclusions from cross-country comparisons at 
this point.  
Deaths amongst midwives and healthcare workers 
The UK has reported deaths of three working midwives from COVID-19, two midwives have died in 
Italy. Over a hundred healthcare staff have died from COVID-19 in both UK and in Italy, and in UK 
there is clear evidence that, as in the general population, staff from BAME backgrounds are 
disproportionately affected, with deaths amongst BAME staff 2-3 times higher than would be 
expected based on the ethnicity profile of the workforce (Cook et al., 2020).  None of the other EU 
countries have reported deaths amongst working midwives. It is unclear why other countries 
severely affected by COVID-19 including France, Spain (and US), have not experienced similar levels 
of death amongst healthcare workers, but it appears that  rates of staff deaths vary widely, with UK 
and Italy reporting the highest rates at present. Inevitably, this leads to questions about the extent 
to which staff were effectively protected, by PPE provision and training or by proactive withdrawal 
from frontline or ‘face to face’ work for those at increased risk, and these questions need to be 
raised within nations and at the global health level, and addressed though rapid and transparent 
enquiry. 
Looking to the future 
COVID-19 will affect maternity care for the foreseeable future, and as COVID-19 rates are increasing 
in the Americas, most EU countries are now attempting to adjust to a ‘new normal’; shops and 
schools are opening, and cafes, restaurants and hotels will follow, bringing concerns about second or 
third waves of infection. Health service providers across Europe struggle with the same set of related 
         
problems; staff shortages as children’s schools and nurseries have closed, healthcare workers who 
have needed to self-isolate, or self-shield during the third trimester of pregnancy, problems 
accessing PPE or effective testing, sickness and even death in the workforce and huge organisational 
restructures to their services affecting midwives, doctors, GPs, and the student workforce. What do 
future maternity services look like in Europe, for midwives and for women and their families, as they 
seek to accommodate and anticipate the possibility of further waves of COVID-19?  
We have seen moves to return to face to face healthcare services, although with ‘social distancing’ 
and expectations that women wear masks, and midwives wear PPE, but this has implications for 
communication and relationship formation. In the Netherlands, midwives have mainly returned to 
providing normal care, with more ‘face to face’ appointments and partners welcome to attend USS 
scans. Nevertheless, midwives across Europe may find it difficult to work as they may have family 
members who need to be shielded from COVID-19, and they may themselves be at increased risk. 
Some UK hospital services have moved staff from black and minority ethnic groups and those with 
chronic health conditions away from ‘frontline’ services, and redeployed them to provide telephone 
or online care, but it is unclear what will happen as services revert to face to face provision. Women, 
midwives and employers across Europe will need to consider how best to keep each other safe. 
The immediate concerns are perhaps also clinical in nature; we need research and information 
sharing to understand the impact of the COVID-19 era on pregnant women. How do we support and 
reassure the majority of pregnant women who are healthy and well? How should we prevent 
perinatal mental health problems whilst we advise women to self-isolate in the third trimester, and 
ensure that women at risk of domestic violence are protected? How much online and telephone 
support is enough, and how many women are missing out? How are women who experience 
perinatal loss being supported? How are women managing after giving birth with reduced visits and 
online breastfeeding support? How do we ensure we remain alert for new and developing problems 
or trends? At a time of great concern about rising interventions during birth, how do we continue to 
         
support women to have a positive pregnancy and birth in the context of sustained COVID-19 
anxiety? Whilst current evidence suggests that pregnant women are not at increased risk of COVID-
19 complications, they remain, as Buerkens et al (2020) argue, vulnerable to social risks and risks 
related to socio-economic and gender inequalities.  
We have a thriving research community in Europe and beyond, and midwives across the world are 
rising to the challenge of finding new ways of working, based on useful, applicable evidence. 
Midwifery journal is planning a special issue to bring together research on COVID-19 in pregnancy, 
and we know that rapid dissemination of good evidence will help; we also know that we should not 
be complacent, and that we need to maintain vigilance and speak up for staff safety and for the safe, 
high quality care for women and families during the COVID-19 era. 
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